国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (4): 276-283.doi: 10. 3760/cma.j.cn115500-20250119-25407

• 综述 • 上一篇    下一篇

晚期囊袋阻滞综合征的发病机制及治疗

杨翼帆 李欣瞳 韩艺琳 徐素 张晶雯 王梓柏 张凤妍   

  1. 郑州大学第一附属医院眼科,郑州 450052
  • 收稿日期:2025-01-19 出版日期:2025-08-22 发布日期:2025-08-12
  • 通讯作者: 张凤妍,Email:zhangfengyanx@aliyun.com E-mail:zhangfengyanx@aliyun.com
  • 基金资助:
    2021年度中原英才计划(育才系列)-中原名医(11679)

Pathogenesis and therapeutic management of late-onset capsular block syndrome

Yang Yifan, Li Xintong, Han Yilin, Xu Su, Zhang Jingwen, Wang Zibo, Zhang Fengyan   

  1. Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Received:2025-01-19 Online:2025-08-22 Published:2025-08-12
  • Contact: Zhang Fengyan, Email: zhangfengyanx@aliyun.com E-mail:zhangfengyanx@aliyun.com
  • Supported by:
    2021 Central Plains Talent Program (Talent Cultivation Series) -Central Plains Famous Doctors (11679)

摘要: 晚期囊袋阻滞综合征(late-onset capsular block syndrome,LCBS)是白内障术后较长时间后因连续环形撕囊口过小、人工晶状体(intraocular lens,IOL)与前囊口粘连形成密闭腔隙,导致液体蓄积所致的囊袋扩张、IOL前移及屈光漂移的眼部综合征。其发病机制涉及三大关键:(1)晶状体上皮细胞增生分泌αB/βB晶状体蛋白及钙离子,驱动渗透梯度形成;(2)痤疮丙酸杆菌潜伏感染诱发乳糜样混浊;(3)炎性因子肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)、白细胞介素-1β(interleukin-1 beta,IL-1β)、碱性成纤维细胞生长因子(basic fibroblast growth factor,BFGF)及白细胞介素-8(interleukin-8,IL-8)介导血-房水屏障破坏。诊断除常规超声生物显微镜(ultrasound biomicroscopy,UBM)和眼前节相干光断层扫描(anterior segment optical coherence tomography,AS-OCT)外,现可借助多模态影像技术提升鉴别效能。Nd:YAG激光前囊切开适用于无后囊膜混浊(posterior capsular opacification,PCO)者;后囊切开对伴PCO者更有效;联合切开可降低复发率;飞秒激光后囊切开联合术中OCT可以突破传统定位限制发挥新优势。前囊松解联合囊液抽吸可以保留后囊屏障;玻璃体切除联合后囊连续环形撕囊术(posterior continuous curvilinear capsulorhexis,PCCC)适用于重度PCO或感染患者,未来需进一步关注个体化防治。

关键词: 晚期囊袋阻滞综合征, 发病机制, 治疗

Abstract: Late-onset capsular block syndrome (LCBS) is an ocular syndrome following cataract surgery characterized by capsular bag distension, intraocular lens (IOL) anterior displacement, and refractive shift, resulting from fluid accumulation within a sealed compartment formed by adhesions between the IOL and a small-diameter continuous curvilinear capsulorhexis (CCC) opening. Its pathogenesis involves three key mechanisms: (1) proliferation of lens epithelial cells secreting αB/βB crystallins and calcium ions to drive osmotic gradient formation; (2)latent Propionibacterium acnes infection inducing chylous opacity; and (3) inflammatory cytokines (TNF-α, IL-1β, BFGF, IL-8) mediating blood-aqueous barrier disruption. Diagnosis, beyond conventional ultrasound biomicroscopy (UBM) and anterior segment optical coherence tomography (AS-OCT), now leverages multimodal imaging to enhance differential diagnostic accuracy. Therapeutic strategies primarily include laser therapy: Nd:YAG laser anterior capsulotomy is indicated for cases without posterior capsular opacification (PCO); posterior capsulotomy proves more effective for PCO-associated LCBS; combined capsulotomy reduces recurrence rates, and femtosecond laser treatment with intraoperative OCT overcomes traditional localization limitations; and surgical intervention involves anterior capsular release with fluid aspiration to preserve the posterior capsular barrier, and pars plana vitrectomy combined with posterior continuous curvilinear capsulorhexis (PCCC) for severe PCO or infected cases, with future efforts focused on individualized prevention and management.

Key words: Late-onset capsular block syndrome, Pathogenesis, Treatment